Determinants of Compliance With Glaucoma Therapy

The purpose of this study is to determine which medical, demographic, and health belief factors are associated with glaucoma therapy compliance.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Open Angle Glaucoma Behavior Eye Diseases Glaucoma Glaucoma, Open-Angle Health Behavior Ocular Hypertension Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Devers Eye Institute

Portland, Oregon, 97210, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

open angle glaucoma
be well controlled on current medical therapy
be using a prostaglandin analogue

Treatment and study plan

Primary outcomes

Compliance with glaucoma medication at 1 month

Time frame: 1 month after enrollment

Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.
Compliance with glaucoma medication at 3 months

Time frame: 3 months after enrollment

Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

Sponsors and collaborators

Lead sponsor

Legacy Health System

Other

Registry information

Important dates

Study start: 2006
Primary completion: 2013
Study completion: 2013
First posted: Dec 2, 2011
Registry last updated: Mar 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed